In resistant tumor models spanning multiple cancer types—including colon, breast, lung, fibrosarcoma, and bladder—higher IL-4 production has been identified as a characteristic feature, distinguishing resistant cells from their non-resistant counterparts [59]. Here, IL4 is linked to cancer.